Photo generated from www.esmoopen.com
Mar 21, 2024, 10:54
The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen – ESMO Open
ESMO Open posted on X:
“Hot off the press: among 757 patients with early HER2+ breast cancer in the Swedish SCAN-B cohort, the HER2DX risk-score as a continuous variable was found significantly associated with OS after adjustment for clinical variables and treatment regimen.”
Read Further
Source: ESMO Open/X
Jul 26, 2024, 08:02